Heartburn Relief Tablet, Film Coated
NDC Package 83059-0031-5

11-digit billing NDC: 83059003105

Package Information

Heartburn Relief (famotidine) tablets is keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away. This formulation utilizes a tablet, film coated delivery system. Marketed by Shield Pharmaceuticals Corp, this product is identified by NDC 83059-0031 and is authorized under FDA application ANDA215766.

Identification & Billing

NDC Package Code
83059-0031-5
Package Description
1 BOTTLE in 1 PACKAGE / 50 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
83059003105
RxNorm Crosswalk
RxCUI: 199047 - famotidine 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Heartburn Relief
Non-Proprietary Name
Famotidine
Substance Name
Famotidine
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) adults and children 12 years and over:to relievesymptoms, swallow 1 tablet with a glass of water. Do not chew. to preventsymptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes beforeeating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hourschildren under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Shield Pharmaceuticals Corp
Product Type
Human Otc Drug
FDA Application #
ANDA215766
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-11-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83059-0031-5 identifies a specific commercial package of 1 bottle in 1 package / 50 tablet, film coated in 1 bottle of Heartburn Relief, a human over the counter drug labeled by Shield Pharmaceuticals Corp. This tablet, film coated is formulated for oral use and contains famotidine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shield Pharmaceuticals Corp on June 11, 2024. The current certification is valid through December 31, 2026.

How is this Shield Pharmaceuticals Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83059003105. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
83059-0031-5
11-Digit CMS (5-4-2)
83059-0031-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.